Topic Collection Cover Page

Bioterrorism and High Consequence Biological Threats
Topic Collection
November 11, 2024

Topic Collection: Bioterrorism and High Consequence Biological Threats

Bioterrorism and other high consequence biological events can result in mass casualties, epidemic illness, healthcare worker illness, environmental contamination, legal issues, and cause unease within the medical community and the community at large. In addition to agents of concern due to their possible use in a bioterrorist attack, this Topic Collection (TC) contains information on other potential high consequence threats from emerging diseases, accidental releases, and scientific advances, such as dual use research and synthetic biology. Biological incidents call for collaboration between multiple disciplines including healthcare, public health, emergency management, and law enforcement and require specific planning and response interventions.

The resources in this TC highlight recent research, promising practices, and model procedures for preparing for, responding to, and recovering from an act of bioterror or widespread illness caused by a high consequence biological agent. This TC is intended as a contemporary annotated bibliography of articles and resources and is not intended to present a comprehensive review of the literature. It provides information about biodefense and bioterrorism and selected specific agents. Medical countermeasure distribution information is found in a separate TC.

Information on additional biological threats and some specific agents may be found in the following TCs (listed alphabetically): Influenza Epidemic/Pandemic; Coronaviruses (e.g., SARS, MERS and COVID-19); Ebola/VHF; and Zika. Information on additional terrorist threats may be found in the Chemical Hazards, Active Shooter and Explosives, and Radiological and Nuclear Collections.

Related information can be found in the following TCs: Crisis Standards of Care, Ethics, Fatality Management, Healthcare-Related Disaster Legal/ Regulatory/ Federal Policy, Hospital Patient Decontamination, Mental/Behavioral Health (non-responders), Pharmacy, Pediatric/Children, Pre-Hospital Patient Decontamination, and Responder Safety and Health. Please click here for a list of all comprehensively developed TCs. 

Sections Navigation

Toggle Open/Close

Must Reads

Adalja, A., Toner, E., and Inglesby, T. (2015). Clinical Management of Potential Bioterrorism-Related Conditions. New England Journal of Medicine. 372:954-62.
The authors review the clinical management of five diseases caused by category A agents: anthrax, smallpox, pneumonic plague, botulism, and tularemia. For anthrax, they discuss the three forms found in humans, special considerations for children and women, diagnosis, treatment, and prevention. For the other four diseases, they describe cardinal features, diagnosis, and treatment and prevention.
Favorite:
You must Login to add a comment
  • This item doesn't have any comments
APIC Bioterrorism Task Force and CDC Hospital Infections Program Bioterrorism Working Group. (1999). Bioterrorism Readiness Plan: A Template for Healthcare Facilities.
In cooperation with the Centers for Disease Control and Prevention (CDC), APIC produced this Bioterrorism Readiness Plan to serve as a reference document and initial template to facilitate preparation of bioterrorism readiness plans for individual institutions.
Favorite:
You must Login to add a comment
  • This item doesn't have any comments
Arnon, S., Schechter, R., Inglesby, T., et al. (2001). Botulinum Toxin as a Biological Weapon. Journal of the American Medical Association, 285(16):2081.
This article highlights recommendations developed by the Working Group on Civilian Biodefense regarding a terrorist event featuring the release of botulinum toxin. The group provides a list of symptoms and treatment suggestions. Some recommendations may be dated but the article provides an excellent overview of Botulism as a weapon.
Favorite:
You must Login to add a comment
  • This item doesn't have any comments
Ashford, D.A., et al. (2003). Planning against Biological Terrorism: Lessons from Outbreak Investigations. Emerging Infectious Diseases. May 9(5):515-519.
This article examines outbreak investigations conducted around the world from 1988 to 1999 and describes lessons learned from outbreak investigations that involved biologic agents with potential for bioterrorism.
Favorite:
You must Login to add a comment
  • This item doesn't have any comments
Association of Public Health Laboratories and American Society for Microbiology. (2016). Clinical Laboratory Preparedness and Response Guide.
This comprehensive guide includes tools and standards that can help laboratories recognize that a specimen contains a biological threat agent, handle said specimens, and notify appropriate state and federal partners. It includes helpful graphics, charts, and links to related resources.
Favorite:
You must Login to add a comment
  • This item doesn't have any comments
Blue Ribbon Panel on Biodefense. (2015). A National Blueprint for Biodefense: Leadership and Major Reform Needed to Optimize Efforts – Bipartisan Report of the Blue Ribbon Study Panel on Biodefense.
This report identifies the need for improvement in biological threat readiness in several areas: achieving coordination and accountability, elevating collaboration, and driving innovation. The panel provides recommendations to address these three areas.
Favorite:
You must Login to add a comment
  • This item doesn't have any comments
Bush, L.M. and Perez, M.T. (2012). The Anthrax Attacks 10 Years Later. Annals of Internal Medicine. 156(1_Part_1):41–44.
This article reviews the lessons learned during the first documented case of the 2001 anthrax attacks. The authors provide in depth details of the initial arrival of the patient to the hospital, physician identification of the agent, internal and external alerting protocols, criminal investigation, challenges within vaccination protocols, and the importance of surveillance for rapid disease identification.
Favorite:
You must Login to add a comment
  • This item doesn't have any comments
California Department of Health Services. (2002). California Hospital Bioterrorism Planning Response Planning Guide.
This guide includes recommendations, references, and standards to help hospitals prepare for a bioterrorism event involving plague, smallpox, and/or viral hemorrhagic fevers. Organized into three planning sections which cover reporting requirements, internal and external communication protocols, and detailed agent information the guide can be modified as needed to integrate into existing emergency response plans.
Favorite:
You must Login to add a comment
  • This item doesn't have any comments
Dembek, Z. (2007). Medical Aspects of Biological Warfare. Office of the Surgeon General, Department of the Army.
This free on-line textbook provides an in-depth historical overview of biological weapons, includes chapters on specific bioterror agents, and provides information on laboratory identification, consequence management, medical management, medical countermeasures, and biosafety and biosurety.
Favorite:
You must Login to add a comment
  • This item doesn't have any comments
Federal Emergency Management Agency. (2023). Biological Incident Annex to the Response and Recovery Federal Interagency Operational Plans.
This document describes the framework for the federal government’s response to and recovery from a naturally-occurring or terrorist-caused biological incident. The annex consists of a base annex that applies to all biological incidents and a branch plan for suspected or actual biological attacks.
Favorite:
You must Login to add a comment
  • This item doesn't have any comments
Grundmann, O. (2014). The Current State of Bioterrorist Attack Surveillance and Preparedness in the US. Risk Management and Healthcare Policy.7:177–187.
The author shares the history and lessons learned from bioterrorism-related events between 1990 and 2010. The article highlights the importance of using critical risk management approaches such as surveillance, monitoring, and risk assessments to enhance preparedness and response capabilities during future bioterrorism events
Favorite:
You must Login to add a comment
  • This item doesn't have any comments
Henderson, D., Inglesby, T., Bartlett, J. (1999). Smallpox as a Biological Weapon: Medical and Public Health Management. Journal of American Medical Association. 281(22): 2127-2137.
This article highlights recommendations developed by the Working Group on Civilian Biodefense regarding a terrorist event featuring the release of Smallpox. The group provides a list of symptoms and treatment suggestions. Some recommendations may be dated but the article provides an excellent overview of Smallpox as a weapon.
Favorite:
You must Login to add a comment
  • This item doesn't have any comments
Inglesby, T., Dennis, D., Henderson, D. et al. (2000). Plague as a Biological Weapon: Medical and Public Health Management. Journal of American Medical Association. 283(17): .
This article highlights recommendations developed by the Working Group on Civilian Biodefense regarding a terrorist event featuring the release of Plague. The group provides a list of symptoms and treatment suggestions. Some recommendations may be dated but the article provides an excellent overview of Plague as a weapon.
Favorite:
You must Login to add a comment
  • This item doesn't have any comments
Inglesby, T., Henderson, D., Bartlett, J. (2000). Anthrax as a Biological Weapon: Medical and Public Health Management. Working Group on Civilian Biodefense. (Abstract only.)
This article highlights recommendations developed by the Working Group on Civilian Biodefense regarding a terrorist event featuring the release of Anthrax. The group provides a list of symptoms and treatment suggestions. Some recommendations may be dated but the article provides an excellent overview of Anthrax as a weapon.
Favorite:
You must Login to add a comment
  • This item doesn't have any comments
Los Angeles County Department of Public Health and Los Angeles County Emergency Medical Services Agency. (2012). Terrorism Agent Information and Treatment Guidelines for Clinicians and Hospitals.
Clinicians and others can use this manual to further their knowledge on bioterrorism agents, chemical and radiological terrorism, infection control, and management of exposed persons.
Favorite:
You must Login to add a comment
  • This item doesn't have any comments
McCarty, C., Angelo, K., Beer, K., et al. (2015). Notes from the Field: Large Outbreak of Botulism Associated with a Church Potluck Meal - Ohio, 2015. Morbidity and Mortality Weekly Report (MMWR).64(29):802-803.
This report provides a summary of the 2015 botulism outbreak in Fairfield County, Ohio. The authors review the public health and medical response from the initial onset of the outbreak through the investigation and identification of the botulism source. The report highlights the importance of coordination among healthcare responders during botulism outbreaks.
Favorite:
You must Login to add a comment
  • This item doesn't have any comments
National Academies of Science and US Department of Homeland Security. (2004). Biological Attack: Human Pathogens, Biotoxins, and Agricultural Threats.
This report brief provides clear, concise information to the media, public, and health care workers on the characteristics, dangers, and consequences associated with various types of attacks.
Favorite:
You must Login to add a comment
  • This item doesn't have any comments
National Academies of Sciences, Engineering, and Medicine. (2018). Biodefense in the Age of Synthetic Biology. The National Academies Press.
This report reviews the uses of synthetic biology and explores potential misuses. The authors develop a framework to assess the security concerns related to advances in synthetic biology, ranks those concerns, and identifies options that could help mitigate the concerns.
Favorite:
You must Login to add a comment
  • This item doesn't have any comments
National Emerging Special Pathogen Training and Education Center. (n.d.). Special Pathogens of Concern. (Accessed 6/25/2018.)
This online course informs healthcare workers of factors of special pathogens that may warrant treatment of infected patients in biocontainment units. The course includes clinical presentation descriptions of viral hemorrhagic fevers and highly pathogenic respiratory viruses.
Favorite:
You must Login to add a comment
  • This item doesn't have any comments
Rainisch, G., Meltzer, M., Shadomy, S., et al. (2017). Modeling Tool for Decision Support During Early Days of an Anthrax Event. Emerging Infectious Diseases. 23(1): 46-55.
The authors developed a model based on the first three days of case data to project cases, peak hospital caseload, and deaths from an inhalational anthrax incident and the effects of interventions on these projections.
Favorite:
You must Login to add a comment
  • This item doesn't have any comments
San Francisco Department of Public Health. (2011). Infectious Disease Emergency Response Plan.
This plan contains the following sections: command, plans section (by unit), operations section, logistics, and finance. Four annexes that focus on different threats are included, as are sample forms and other appendices.
Favorite:
You must Login to add a comment
  • This item doesn't have any comments
Smith, P., Anderson, A., Christopher, G., et al. (2006). Designing a Biocontainment Unit to Care for Patients with Serious Communicable Diseases: A Consensus Statement. (Abstract only.) Biosecurity and Bioterrorism: Biodefense Strategy, Practice, and Science. 4(4):351-365.
The authors synthesized consensus recommendations collected from a conference of civilian and military professionals who are involved in the various aspects of biocontainment patient care units. Appendices include in-depth information on medical care issues (e.g., staffing the units, pathology, housekeeping), infection control issues (e.g., personal protective equipment, dealing with infectious waste), facility issues (e.g., air-handling, communication), and psychosocial and ethical issues.
Favorite:
You must Login to add a comment
  • This item doesn't have any comments
Toner, E., Shearer, M., Kirk Sell, T., et al. (2017). Health Sector Resilience Checklist for High Consequence Infectious Diseases – Informed by the Domestic U.S. Ebola Response. Johns Hopkins Bloomberg School of Public Health Center for Health Security.
This document provides action steps for responding to isolated cases or limited outbreaks of high-consequence infectious diseases, including those that are: novel or rare in the community, moderate to highly contagious, moderate to highly lethal, not easily controlled by medical countermeasures and other interventions, and have the potential to cause exceptional public concern. The document includes a general checklist and population-specific checklists for public health, healthcare, emergency medical services, and elected officials.
Favorite:
You must Login to add a comment
  • Bridget Kanawati Thank you for letting us know. The link has been updated with the new URL.
    7/27/2023 10:32:26 AM
  • Jonathan Pearson This link seems to be broken.
    7/27/2023 10:07:17 AM
Trust for America’s Health. (2011). Remembering 9/11 and Anthrax Attacks: Public Health’s Vital Role in National Defense.
This issue report reviews lessons learned during the 2001 anthrax attacks through in-depth interviews with responding professionals from local, state, and federal public health agencies. They discuss their experiences during the 2001 attacks, reflect on the progress made within the 10 years since the attack, identify ongoing preparedness gaps, and provide recommendations for sustaining public health emergency response capabilities through all hazards planning.
Favorite:
You must Login to add a comment
  • This item doesn't have any comments
U.S. Army Medical Research Institute on Infectious Diseases. (2020). Medical Management of Biological Casualties Handbook, 9th Edition.
Known informally as the “Blue Book,” this handbook provides an overview of the history of biological warfare and current threats and information on distinguishing between naturally-occurring and intentional disease outbreaks, discusses biosurveillance, offers ten steps in the management of potential biological casualties, notes emerging threats and potential biological weapons, and provides information on personal protection, field detection, and decontamination. Chapters are devoted to specific bacterial agents, viral agents, and biological toxins.
Favorite:
You must Login to add a comment
  • This item doesn't have any comments
U.S. Environmental Protection Agency. (2016). Best Practices for Management of Biocontaminated Waste.
This document provides best practices for waste management activities during a biological incident response.
Favorite:
You must Login to add a comment
  • This item doesn't have any comments
World Health Organization. (2018). Managing Epidemics: Key Facts about Major Deadly Diseases.
This handbook offers an overview of infectious disease threats and the importance of effectively managing them, provides 10 key facts on 15 deadly diseases, and contains three toolboxes (the role of WHO, the International Coordinating Group on vaccine provision, and tables for laboratory diagnosis and shipment of infectious substances).
Favorite:
You must Login to add a comment
  • This item doesn't have any comments

Biodefense Policy and Strategy

American Society for Microbiology. (2018). Global Threats, Collaborative Solutions – Combatting Emerging Biothreats, U.S. Agencies Perspectives.
This recorded conference session features staff from the Centers for Disease Control and Prevention, the Department of Defense, and the U.S. Agency for International Development describing their work in global health security.
Favorite:
You must Login to add a comment
  • This item doesn't have any comments
Blue Ribbon Panel on Biodefense. (2015). A National Blueprint for Biodefense: Leadership and Major Reform Needed to Optimize Efforts – Bipartisan Report of the Blue Ribbon Study Panel on Biodefense.
This report identifies the need for improvement in biological threat readiness in several areas: achieving coordination and accountability, elevating collaboration, and driving innovation. The panel provides recommendations to address these three areas.
Favorite:
You must Login to add a comment
  • This item doesn't have any comments
Blue Ribbon Panel on Biodefense. (2018). Transnational Biological Threats and Global Security.
This public meeting recording features presentations on current biological threats, global homeland defense and security, global efforts to combat these types of threats, international public health security, and elevating global health security as a priority.
Favorite:
You must Login to add a comment
  • This item doesn't have any comments
* National Academies of Sciences, Engineering, and Medicine. (2018). Biodefense in the Age of Synthetic Biology. The National Academies Press.
This report reviews the uses of synthetic biology and explores potential misuses. The authors develop a framework to assess the security concerns related to advances in synthetic biology, ranks those concerns, and identifies options that could help mitigate the concerns.
Favorite:
You must Login to add a comment
  • This item doesn't have any comments
Schoch-Spana, M., Cicero, A., Adalja, A. et al. (2017). Global Catastrophic Biological Risks: Toward a Working Definition. Health Security. 15(4): 323-328.
This article analyzes potential global catastrophic biological risks to further enhance dialogue, clearly define the category of risks, and improve preparedness and response efforts to minimize the impacts of disasters and epidemics associated with such biological threats. The authors review past epidemics such as H5N1, 2009 H1N1, and the 1918 influenza pandemic and hypothesize the impact of additional biological, and technological events, which could damage national governments, international relationships, societal stability, and global security.
Favorite:
You must Login to add a comment
  • This item doesn't have any comments
The White House. (2010). Executive Order 13546: Optimizing the Security of Biological Select Agents and Toxins in the United States. Federal Register. 75(130):39439-39442.
This Executive Order: expresses the importance of scientific research with biological select agents and toxins as it relates to national security; highlights security requirements relative to misuse, theft, loss, and accidental release; and emphasizes the need for security that balances their efficacy with the minimization of adverse impacts on legitimate use.
Favorite:
You must Login to add a comment
  • This item doesn't have any comments
Tian, D. and Zheng, T. (2014). Comparison and Analysis of Biological Agent Category Lists Based on Biosafety and Biodefense. PLoS One. 9(6).
The authors compared and analyzed laboratory biosafety category lists and biological agent biodefense lists from multiple countries. They recommended increased consistency in naming biological agent categories and assigning risk levels to improve laboratory safety, communication, and situation management. They also suggested that developing nations develop their own biodefense lists reflecting their threats and capabilities. The authors note that international collaboration is required to achieve their recommendations.
Favorite:
You must Login to add a comment
  • This item doesn't have any comments
* Toner, E., Shearer, M., Kirk Sell, T., et al. (2017). Health Sector Resilience Checklist for High Consequence Infectious Diseases – Informed by the Domestic U.S. Ebola Response. Johns Hopkins Bloomberg School of Public Health Center for Health Security.
This document provides action steps for responding to isolated cases or limited outbreaks of high-consequence infectious diseases, including those that are: novel or rare in the community, moderate to highly contagious, moderate to highly lethal, not easily controlled by medical countermeasures and other interventions, and have the potential to cause exceptional public concern. The document includes a general checklist and population-specific checklists for public health, healthcare, emergency medical services, and elected officials.
Favorite:
You must Login to add a comment
  • Bridget Kanawati Thank you for letting us know. The link has been updated with the new URL.
    7/27/2023 10:32:26 AM
  • Jonathan Pearson This link seems to be broken.
    7/27/2023 10:07:17 AM
U.S. Department of Health and Human Services. (2017). Possession, Use, and Transfer of Select Agents and Toxins; Biennial Review of the List of Select Agents and Toxins and Enhanced Biosafety Requirements. Federal Register. 82(12):6278-6294.
This notice summarizes the Centers for Disease Control and Prevention’s required biennial review of the list of biological agents and toxins with potential to pose a severe threat to public health and safety.
Favorite:
You must Login to add a comment
  • This item doesn't have any comments
U.S. Food and Drug Administration. (n.d.). MCM Legal, Regulatory and Policy Framework. (Accessed 1/30/2022.)
The FDA works within this framework to ensure that U.S. laws, regulations and policies help support preparedness and response for potential chemical, biological, radiological, nuclear (CBRN) and emerging infectious disease threats. This webpage includes links to related legislation, emergency use authorities of the FDA, and legal and policy presentations, publications, and other information.
Favorite:
You must Login to add a comment
  • This item doesn't have any comments
U.S. Government Accountabily Office. (2017). Federal Efforts to Develop Biological Threat Awareness.
This report describes how federal agencies develop biological threat awareness, use that information to support investment decisions, share threat awareness among agencies, and determine additional threat characterization knowledge to pursue.
Favorite:
You must Login to add a comment
  • This item doesn't have any comments
Wagar, E. (2016). Bioterrorism and the Role of the Clinical Microbiology Laboratory. Clinical Microbiology Reviews. 29(1):175-189 .
This article provides an overview of the history of bioterrorism, the development of the Laboratory Response Network, and the important role of clinical microbiology labs in supporting response efforts. The author reviews agents that pose a high risk of occupational exposure and discusses the importance of risk assessments and management resources such as templates and checklists to worker safety and laboratory performance.
Favorite:
You must Login to add a comment
  • This item doesn't have any comments

Clinical Management

Adalja, A. (2018). Biothreat Agents and Emerging Infectious Disease in the Emergency Department. (First page only.) Emergency Medicine Clinics of North America. 36(4):823-834.
The author describes the role of emergency department clinicians in recognizing and containing potential emerging infectious disease outbreaks.
Favorite:
You must Login to add a comment
  • This item doesn't have any comments
Adalja, A., Toner, E., and Inglesby, T. (2015). Clinical Management of Potential Bioterrorism-Related Conditions. New England Journal of Medicine. 372:954-62.
The authors review the clinical management of five diseases caused by category A agents: anthrax, smallpox, pneumonic plague, botulism, and tularemia. For anthrax, they discuss the three forms found in humans, special considerations for children and women, diagnosis, treatment, and prevention. For the other four diseases, they describe cardinal features, diagnosis, and treatment and prevention.
Favorite:
You must Login to add a comment
  • This item doesn't have any comments
Busl, K. and Bleck, T. (2012). Treatment of Neuroterrorism. Neurotherapeutics. 9(1):139-157.
The authors discuss the neurological effects of biological and chemical agents/toxins that may be used for terrorism, and the role that neurologists must play in identifying and treating them. This includes how to determine when observed neurological effects are the result of exposure to biological or chemical terrorism, or the result of naturally-occurring disease.
Favorite:
You must Login to add a comment
  • This item doesn't have any comments
Centers for Disease Control and Prevention. (2024). Smallpox: Prevention and Treatment.
This webpage explains how the smallpox vaccine can help prevent infection (prior to or within days of exposure) and lists three antiviral drugs that have been shown effective against smallpox: Tecovirimat, Cidofovir, and Brincidofovir.
Favorite:
You must Login to add a comment
  • This item doesn't have any comments
Petersen, B., Damon, I., Pertowski, C., et al. (2015). Clinical Guidance for Smallpox Vaccine Use in a Postevent Vaccination Program. Morbidity and Mortality Weekly Report. 64(RR02):1-26.
This report provides recommendations for the clinical use of the three smallpox vaccines included in the Strategic National Stockpile for persons exposed to the virus or at high risk for infection during a post-event vaccination program. Descriptions, administration and dosage, regulatory status, efficacy, and safety information are included for each vaccine. The report also includes recommendations on use, including considerations for contraindications and special populations, and identifies remaining knowledge gaps and areas for future research.
Favorite:
You must Login to add a comment
  • This item doesn't have any comments
Ramasamy, S., Liu, C., Tran, H., et al. (2010). Principles of Antidote Pharmacology: An Update on Prophylaxis, Post-Exposure Treatment Recommendations and Research Initiatives for Biological Agents. British Journal of Pharmacology. 161(4):721-748.
The authors reviewed literature to identify new prophylaxis and post-exposure treatment research and recommendations for bioterror agents. They provided a summary table of biological agents by type with mode/mechanism of action and signs and symptoms of infection followed by current prophylaxis and treatment options.
Favorite:
You must Login to add a comment
  • This item doesn't have any comments

Education and Training

Ashford, D.A., et al. (2003). Planning against Biological Terrorism: Lessons from Outbreak Investigations. Emerging Infectious Diseases. May 9(5):515-519.
This article examines outbreak investigations conducted around the world from 1988 to 1999 and describes lessons learned from outbreak investigations that involved biologic agents with potential for bioterrorism.
Favorite:
You must Login to add a comment
  • This item doesn't have any comments
Department of Emergency Health Services. (2018). Emerging Infectious Diseases Videos for Prehospital Providers. University of Maryland Baltimore County.
This instructional series, comprised of nine modules (listed at the top of the page), includes an introduction to infectious diseases, basic infection control concepts, considerations for personal protective equipment (including donning and doffing), personnel decontamination, patient transport, and transfer of patient care for patients with Ebola and other highly infectious diseases.
Favorite:
1
You must Login to add a comment
  • This item doesn't have any comments
Mountain Plains Regional Disaster Health Response System. (2024). Just-in-Time Learning Series.
This webpage provides links to various recordings healthcare providers can use "just in time" to treat patients who have been exposed to a variety of threats (e.g., biological, radiological, and chemical agents) or who may be practicing outside of their area of expertise in a medical surge event. Subject matter experts present on a diverse range of topics relevant to disaster preparedness and response in these 15-30 minutes modules. Considerations are also made for treating special populations (e.g., older patients and pregnant patients) in a disaster setting.
Favorite:
You must Login to add a comment
  • This item doesn't have any comments
National Emerging Special Pathogen Training and Education Center. (n.d.). Special Pathogens of Concern. (Accessed 6/25/2018.)
This online course informs healthcare workers of factors of special pathogens that may warrant treatment of infected patients in biocontainment units. The course includes clinical presentation descriptions of viral hemorrhagic fevers and highly pathogenic respiratory viruses.
Favorite:
You must Login to add a comment
  • This item doesn't have any comments
Siegal, D., Strauss-Riggs, K. et al. (2014). Prioritization of Pediatric CBRNE Disaster Education and Training Needs. Clinical Pediatric Emergency Medicine. 15(4):309-317.
This article summarizes the 2011 Pediatric Disaster Preparedness Conference convened by the National Center for Disaster Medicine and Public Health. Multidisciplinary subject matter experts identified and prioritized roles in need of training in three settings: EMS/first responder, hospitals, and ambulatory care. For each role in each setting, experts identified training topics, key content, and level of training required. The authors suggest that a steering committee oversee development and implementation of related curriculum.
Favorite:
You must Login to add a comment
  • This item doesn't have any comments
U.S. Army Medical Research Institute on Infectious Diseases. (n.d.). Medical Management of Chemical and Biological Casualties Course. (Accessed 3/6/2023.)
This six-day course includes classroom instruction, laboratory experience, and field exercises. Participation is open to military and civilian physicians, nurses, physician assistants, senior medical non-commissioned officers, and other medical professionals.
Favorite:
You must Login to add a comment
  • This item doesn't have any comments
Williams, M. and Sizemore, D. (2019). Biologic, Chemical, and Radiation Terrorism Review. StatPearls.
This article outlines biologic, chemical, and radiation terrorism and related issues for healthcare providers. The authors provide guidance on personal protective equipment, decontamination, and preparedness. A quiz based on information presented in the article is included as an additional education aide.
Favorite:
You must Login to add a comment
  • This item doesn't have any comments
World Health Organization. (n.d.). Pandemic and Epidemic-Prone Diseases. (Accessed 7/10/2019.)
This six-hour online course provides information on the management of outbreaks of 13 infectious hazards with pandemic and epidemic potential.
Favorite:
You must Login to add a comment
  • This item doesn't have any comments
World Health Organization. (2018). Managing Epidemics: Key Facts about Major Deadly Diseases.
This handbook offers an overview of infectious disease threats and the importance of effectively managing them, provides 10 key facts on 15 deadly diseases, and contains three toolboxes (the role of WHO, the International Coordinating Group on vaccine provision, and tables for laboratory diagnosis and shipment of infectious substances).
Favorite:
You must Login to add a comment
  • This item doesn't have any comments

Guidance and Guidelines

Association of Public Health Laboratories and American Society for Microbiology. (2016). Clinical Laboratory Preparedness and Response Guide.
This guide includes tools and standards to help laboratories recognize that a specimen contains a biological threat agent, reference testing standards, and notify appropriate state and federal partners.
Favorite:
You must Login to add a comment
  • This item doesn't have any comments
ASTM. (n.d.). Standard Guide for Operational Guidelines for Initial Response to a Suspected Biothreat Agent. (Abstract only; PDF available for purchase; accessed 7/10/19.) West Conshohocken, PA, ASTM International.
These standards can help responder agencies build operational guidelines for the preparedness for, response to, and recovery from a potential biothreat agent.
Favorite:
You must Login to add a comment
  • This item doesn't have any comments
California Department of Health Services. (2002). California Hospital Bioterrorism Planning Response Planning Guide.
This guide includes recommendations, references, and standards to help hospitals prepare for a bioterrorism event involving plague, smallpox, and/or viral hemorrhagic fevers. Organized into three planning sections which cover reporting requirements, internal and external communication protocols, and detailed agent information the guide can be modified as needed to integrate into existing emergency response plans.
Favorite:
You must Login to add a comment
  • This item doesn't have any comments
Centers for Disease Control and Prevention. (2016). Smallpox Vaccines.
This webpage includes links to current smallpox vaccine recommendations developed by the Advisory Committee on Immunization Practices. Current guidance is available for: use of smallpox vaccine in laboratory and health care personnel at risk for occupational exposure to orthopoxviruses, notice of newly licensed vaccine, surveillance guidelines for vaccine adverse reactions, and recommendations for using smallpox vaccine in a pre-event vaccination program.
Favorite:
You must Login to add a comment
  • This item doesn't have any comments
Dembek, Z. (2007). Medical Aspects of Biological Warfare. Office of the Surgeon General, Department of the Army.
This free on-line textbook provides an in-depth historical overview of biological weapons, includes chapters on specific bioterror agents, and provides information on laboratory identification, consequence management, medical management, medical countermeasures, and biosafety and biosurety.
Favorite:
You must Login to add a comment
  • This item doesn't have any comments
European Medicines Agency. (2014). Guidance Document on Use of Medicinal Products for Treatment and Prophylaxis of Biological Agents that Might Be Used as Weapons of Bioterrorism.
This document includes guidance for 10 specific agents and has one chapter on “other infectious diseases” and another on agents for which no treatment can be recommended (e.g., ricin and viral encephalitis). Some medications and trade names differ from those available in the United States.
Favorite:
You must Login to add a comment
  • This item doesn't have any comments
Heymann, D.L. (2014). Control of Communicable Diseases Manual, 20th Edition. (Book available for purchase) American Public Health Association (APHA) Press.
This book (available for purchase as hard copy or electronic download) provides information on more than 130 infectious diseases. It contains information about the occurrence, transmission, and methods of control for each disease. It also includes information on availability and location of available medical treatment stockpiles.
Favorite:
You must Login to add a comment
  • This item doesn't have any comments
Infectious Diseases Society of America. (2016). ID-Focused Hospital Efficiency Improvement Program.
This guide for infectious disease physician executives identifies service lines and related metrics to mitigate infectious disease-related issues. The guide addresses four areas: infection prevention and control; antimicrobial stewardship; outpatient parenteral antimicrobial therapy hospital admission/readmission avoidance; and bio-security, bio-preparedness, and emerging infectious diseases.
Favorite:
You must Login to add a comment
  • This item doesn't have any comments
Los Angeles County Department of Public Health and Los Angeles County Emergency Medical Services Agency. (2012). Terrorism Agent Information and Treatment Guidelines for Clinicians and Hospitals.
Clinicians and others can use this manual to further their knowledge on bioterrorism agents, chemical and radiological terrorism, infection control, and management of exposed persons.
Favorite:
You must Login to add a comment
  • This item doesn't have any comments
* National Academies of Science and US Department of Homeland Security. (2004). Biological Attack: Human Pathogens, Biotoxins, and Agricultural Threats.
This report brief provides clear, concise information to the media, public, and health care workers on the characteristics, dangers, and consequences associated with various types of attacks.
Favorite:
You must Login to add a comment
  • This item doesn't have any comments
National Academies of Sciences, Engineering, and Medicine. (2017). Building a National Capability to Monitor and Assess Medical Countermeasure Use During a Public Health Emergency: Going Beyond the Last Mile: Proceedings of a Workshop. The National Academies Press.
Workshop participants discussed the need for shared terminologies; data needs, sources, and collection methodologies; considerations for conducting rapid clinical research on medical countermeasures (MCM) during a public health emergency; and the federal perspective on MCM. Lessons from a 2012 fungal infection outbreak, anthrax, and H1N1 are shared in sidebars throughout the proceedings.
Favorite:
You must Login to add a comment
  • This item doesn't have any comments
National Emerging Special Pathogens Training and Education Center. (2024). EMS Procedural Guidelines for Special Pathogens.
These model procedural guidelines, created by NETEC's EMS/Patient Transport Work Group, are designed to help EMS agencies develop standard operating procedures for the transport and management of patients suspected or confirmed to have a high-consequence infectious disease. The guidelines address personal protective equipment (PPE) donning and doffing, EMS provider down, PPE breaches, biohazard spills, waste management, ambulance modification, and ambulance cleaning and disinfection. They complement ASPR TRACIE's EMS Infectious Disease Playbook (https://files.asprtracie.hhs.gov/documents/aspr-tracie-transport-playbook-508.pdf).
Favorite:
You must Login to add a comment
  • This item doesn't have any comments
Nolte, K., Hanzlick, R., Payne, D., et al. (2004). Medical Examiners, Coroners, and Biologic Terrorism: A Guidebook for Surveillance and Case Management. Morbidity and Mortality Weekly Report. 53(RR08):1-27.
This report provides information that can help medical examiners and coroners understand their roles in bioterrorism surveillance and response. It provides details on biological threats and laboratory testing procedures, biosafety concerns related to conducting autopsies and dealing with contaminants, and coordination with partners in surveillance, data analysis, evidence collection, and communications.
Favorite:
You must Login to add a comment
  • This item doesn't have any comments
Rebmann, T. (2014). Infectious Disease Disasters: Bioterrorism, Emerging Infections, and Pandemics. APIC Text of Infection Control and Epidemiology.
This book chapter (available for viewing in PDF form) defines infectious disease disasters and highlights the need for specialized emergency planning and response, particularly for infection preventionists.
Favorite:
You must Login to add a comment
  • This item doesn't have any comments
Rybka, A., Gavel, A., and Kroupa, T., et al. (2021). Peracetic Acid-Based Disinfectant is the Most Appropriate Solution for a Biological Decontamination Procedure of Responders and Healthcare Workers in the Field Environment. Journal of Applied Microbiology. 131(3):1240-1248.
This article examined disinfectants’ effectiveness in the field during a biological contamination incident. The authors tested the disinfectants under many variables and determined the optimal peracetic acid concentration and application time for decontamination.
Favorite:
You must Login to add a comment
  • This item doesn't have any comments
Southern Illinois University School of Medicine. (n.d.). Overview of Potential Agents of Biological Terrorism. (Accessed 7/10/2019.)
This webpage includes information on how infectious agents can be used in mass casualty incidents and historical background and trends. The following information is provided for select category A, B, and C agents: microbiology and epidemiology, clinical features, laboratory diagnosis, antimicrobial therapy, post exposure prophylaxis, vaccination, and infection control procedures/ management.
Favorite:
You must Login to add a comment
  • This item doesn't have any comments
U.S. Army Medical Research Institute on Infectious Diseases. (2020). Medical Management of Biological Casualties Handbook, 9th Edition.
Known informally as the “Blue Book,” this handbook provides an overview of the history of biological warfare and current threats and information on distinguishing between naturally-occurring and intentional disease outbreaks, discusses biosurveillance, offers ten steps in the management of potential biological casualties, notes emerging threats and potential biological weapons, and provides information on personal protection, field detection, and decontamination. Chapters are devoted to specific bacterial agents, viral agents, and biological toxins.
Favorite:
You must Login to add a comment
  • This item doesn't have any comments
U.S. Department of Health and Human Services. (2017). Framework for Guiding Funding Decisions about Proposed Research Involving Enhanced Potential Pandemic Pathogens.
This document provides guidance on federal funding of research involving potential pandemic pathogens and highlights the potential benefits of the research and the potential to create, transfer, or use an enhanced potential pandemic pathogen.
Favorite:
You must Login to add a comment
  • This item doesn't have any comments
U.S. Department of Health and Human Services, U.S. Department of Homeland Security, U.S. Department of Labor, and U.S. Environmental Protection Agency. (2012). Guidance for Protecting Responders’ Health During the First Week Following a Wide-Area Aerosol Anthrax Attack.
This document provides guidance on post-exposure prophylaxis and vaccination, personal protective equipment, personal decontamination and hygiene, administrative and engineering controls, and pre-event vaccination for first responders, emergency management staff, public health and medical professionals, skilled support personnel, and critical infrastructure personnel who participate in the response to an anthrax attack.
Favorite:
You must Login to add a comment
  • This item doesn't have any comments
U.S. Environmental Protection Agency. (2016). Best Practices for Management of Biocontaminated Waste.
This document provides best practices for waste management activities during a biological incident response.
Favorite:
You must Login to add a comment
  • This item doesn't have any comments
U.S. Food and Drug Administration. (2019). Emergency Use Authorization.
This authorization allows the Food and Drug Administration to facilitate the availability and use of medical countermeasures to assist during public health emergencies. Links to information on current authorizations (e.g., anthrax, Ebola, and nerve agent) is provided on this page.
Favorite:
1
You must Login to add a comment
  • This item doesn't have any comments
U.S. Food and Drug Administration. (2019). Products Approved for Other Bioterrorism Emergencies.
This webpage includes links to information and guidance on products approved for use during bioterrorism emergencies, specifically for botulism, Ebola virus disease, plague, smallpox, tularemia, and Zika virus disease.
Favorite:
You must Login to add a comment
  • This item doesn't have any comments
U.S. Food and Drug Administration. (2023). Medical Countermeasure Monitoring and Assessment.
This webpage is focused on the need to build and maintain a national capability to monitor and assess medical countermeasures (MCMs) after they are dispensed or administered in response to a chemical, biological, radiological, or nuclear threat or an emerging infectious disease. Links to “FDA Information about Past and Current MCM Monitoring and Assessment Projects” are included
Favorite:
You must Login to add a comment
  • This item doesn't have any comments
Various Authors. (2014). Special Issue. Clinical Microbiology and Infection. 20(6).
This issue includes several articles that dispel bioterrorism-related myths and provide clear insight on the impacts to healthcare workers, dual use research, and historical perspective on biological warfare.
Favorite:
You must Login to add a comment
  • This item doesn't have any comments
Various Federal Agencies. (2019). Managing Solid Waste Contaminated with a Category A Infectious Substance: Summary.
This is a summary of a guidance document based on extensive federal interagency coordination and stakeholder input and designed to help those who work in healthcare facilities, medical transportation operations, and laboratories better understand infectious waste and how to manage it. Access the full report at https://www.phmsa.dot.gov/sites/phmsa.dot.gov/files/docs/transporting-infectious-substances/6821/cat-waste-planning-guidance-final-2019-08.pdf.
Favorite:
You must Login to add a comment
  • This item doesn't have any comments
Various Federal Agencies. (2024). Planning Guidance for Handling Category A Solid Waste.
Based on extensive federal interagency coordination and stakeholder input, the guidance in this document can help those who work in healthcare facilities, medical transportation operations, and laboratories better understand infectious waste and how to manage it.
Favorite:
You must Login to add a comment
  • This item doesn't have any comments
Williams, M. and Sizemore, D. (2019). Biologic, Chemical, and Radiation Terrorism Review. StatPearls.
This article outlines biologic, chemical, and radiation terrorism and related issues for healthcare providers. The authors provide guidance on personal protective equipment, decontamination, and preparedness. A quiz based on information presented in the article is included as an additional education aide.
Favorite:
You must Login to add a comment
  • This item doesn't have any comments
Wright, J., Quinn, C., Shadomy, S., et al. (2010). Use of Anthrax Vaccine in the United States: Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2009. Morbidity and Mortality Weekly Report. 59(RR06):1-30.
This Mortality and Morbidity Weekly Report provides recommendations from the Advisory Committee on Immunization Practices (ACIP) for anthrax vaccine adsorbed (AVA). The report discusses updated information on anthrax epidemiology, and summarizes the evidence regarding the effectiveness and efficacy, immunogenicity, and safety of the AVA vaccine. Authors identify areas for future research and conclude by providing recommendations for pre-exposure and post-exposure use in general and specific subpopulations, including children, pregnant and breastfeeding women, and those with various occupational exposures.
Favorite:
You must Login to add a comment
  • This item doesn't have any comments

Lessons Learned

Ashford, D.A., et al. (2003). Planning against Biological Terrorism: Lessons from Outbreak Investigations. Emerging Infectious Diseases. May 9(5):515-519.
This article examines outbreak investigations conducted around the world from 1988 to 1999 and describes lessons learned from outbreak investigations that involved biologic agents with potential for bioterrorism.
Favorite:
You must Login to add a comment
  • This item doesn't have any comments
Bush, L.M. and Perez, M.T. (2012). The Anthrax Attacks 10 Years Later. Annals of Internal Medicine. 156(1_Part_1):41–44.
This article reviews the lessons learned during the first documented case of the 2001 anthrax attacks. The authors provide in depth details of the initial arrival of the patient to the hospital, physician identification of the agent, internal and external alerting protocols, criminal investigation, challenges within vaccination protocols, and the importance of surveillance for rapid disease identification.
Favorite:
You must Login to add a comment
  • This item doesn't have any comments
Chess, C. and Clarke, L. (2007). Facilitation of Risk Communication During the Anthrax Attacks of 2001: The Organizational Backstory. American Journal of Public Health. 97(9): 1578–1583.
This article provides lessons learned in risk communication by New Jersey-based hospital, public health, and emergency management responders during the 2001 anthrax attacks. The authors identified interorganizational relationships, organizational culture, and differences in medical and scientific interpretation as attributing to communication challenges faced by responders. The article concludes by reinforcing the importance of command and control while highlighting the need for additional research on organizational culture and the impact it has on risk communication.
Favorite:
You must Login to add a comment
  • This item doesn't have any comments
Dworkin, M.S, Ma, X., and Golash, R.G. (2003). Fear of Bioterrorism and Implications for Public Health Preparedness. Emerging Infectious Diseases. April 9(4):503-505.
This article describes the dramatic increase in the number of environmental and human samples submitted as a result of human anthrax cases and exposures in 2001, and discusses implications for laboratory surge capacity planning.
Favorite:
You must Login to add a comment
  • This item doesn't have any comments
Grundmann, O. (2014). The Current State of Bioterrorist Attack Surveillance and Preparedness in the US. Risk Management and Healthcare Policy.7:177–187.
The author shares the history and lessons learned from bioterrorism-related events between 1990 and 2010. The article highlights the importance of using critical risk management approaches such as surveillance, monitoring, and risk assessments to enhance preparedness and response capabilities during future bioterrorism events
Favorite:
You must Login to add a comment
  • This item doesn't have any comments
* National Academies of Science and US Department of Homeland Security. (2004). Biological Attack: Human Pathogens, Biotoxins, and Agricultural Threats.
This report brief provides clear, concise information to the media, public, and health care workers on the characteristics, dangers, and consequences associated with various types of attacks.
Favorite:
You must Login to add a comment
  • This item doesn't have any comments
* National Academies of Sciences, Engineering, and Medicine. (2005). The Smallpox Vaccination Program: Public Health in the Age of Terrorism.
This document reviews the Centers for Disease Control and Prevention’s implementation of its smallpox vaccination program. The report explores the history of smallpox and its control, provides a policy context for the program, offers a chronology of the program’s implementation, and discusses lessons learned.
Favorite:
You must Login to add a comment
  • This item doesn't have any comments
Smith, P., Anderson, A., Christopher, G., et al. (2006). Designing a Biocontainment Unit to Care for Patients with Serious Communicable Diseases: A Consensus Statement. (Abstract only.) Biosecurity and Bioterrorism: Biodefense Strategy, Practice, and Science. 4(4):351-365.
The authors synthesized consensus recommendations collected from a conference of civilian and military professionals who are involved in the various aspects of biocontainment patient care units. Appendices include in-depth information on medical care issues (e.g., staffing the units, pathology, housekeeping), infection control issues (e.g., personal protective equipment, dealing with infectious waste), facility issues (e.g., air-handling, communication), and psychosocial and ethical issues.
Favorite:
You must Login to add a comment
  • This item doesn't have any comments
Toner, E., Shearer, M., Kirk Sell, T., et al. (2017). Health Sector Resilience Checklist for High Consequence Infectious Diseases—Informed by the Domestic US Ebola Response. Centers for Disease Control and Prevention.
The authors discuss the process they used to develop the checklist for isolated cases or limited outbreaks of high consequence infectious disease (e.g., Ebola, Marburg, Lassa, smallpox, SARS, MERS, and H5N1 influenza A). The checklist can help medical and public health authorities work with nongovernmental organizations and private industry, to assess and bolster community health sector resilience.
Favorite:
1
You must Login to add a comment
  • This item doesn't have any comments
Trust for America’s Health. (2011). Remembering 9/11 and Anthrax Attacks: Public Health’s Vital Role in National Defense.
This issue report reviews lessons learned during the 2001 anthrax attacks through in-depth interviews with responding professionals from local, state, and federal public health agencies. They discuss their experiences during the 2001 attacks, reflect on the progress made within the 10 years since the attack, identify ongoing preparedness gaps, and provide recommendations for sustaining public health emergency response capabilities through all hazards planning.
Favorite:
You must Login to add a comment
  • This item doesn't have any comments
* U.S. Department of Homeland Security. (2012). Urban Area Recovery Planning with CBR (Chemical, Biological, Radiological Hazards: Lessons Learned from Seattle and Denver).
This planning aid can help multijurisdictional urban area planners manage the recovery from a biological, chemical, or radiological event. Developed from lessons learned during events in Seattle (WA) and Denver (CO), the document provides a recovery planning template along with corresponding planning support annexes for each of the three hazards.
Favorite:
You must Login to add a comment
  • This item doesn't have any comments
Weiss, S., Yitzhaki, S., and Shapira, S.C. (2015). Lessons to be Learned from Recent Biosafety Incidents in the United States. Israeli Medical Association Journal. 17(5):269-273.
The authors described lessons learned from three major biosafety incidents that occurred at the Centers for Disease Control and Prevention, the National Institutes of Health, and the U.S. Food and Drug Administration. They discuss the importance of establishing biosafety management programs and maintaining a culture of safety and reliability to prevent future biosafety incidents
Favorite:
You must Login to add a comment
  • This item doesn't have any comments

Pediatric and Maternal Health Issues

American Academy of Pediatrics. (n.d.). Biological Terrorism and Agents. (Accessed 7/10/2019.)
This webpage provides an overview of children and bioterrorism, and the response role of pediatricians during bioterrorism incidents. It includes links to information on Category A, B, and C bioterrorism agents, information on pediatrician-specific roles and responsibilities, strategies for office practice, and recommendations for future collaborative efforts.
Favorite:
You must Login to add a comment
  • This item doesn't have any comments
Bartenfeld, M., Peacock, G., and Griese, S. (2014). Public Health Emergency Planning for Children in Chemical, Biological, Radiological, and Nuclear (CBRN) Disasters. Biosecurity and Bioterrorism. 12(4):201-207.
The authors discuss the distinguishable physical, developmental, and social traits and characteristics of children in the context of chemical, biological, radiological, and nuclear (CBRN) incidents. This includes the science behind exposure, health effects, and treatment for exposure to potential agents during CBRN events.
Favorite:
You must Login to add a comment
  • This item doesn't have any comments
Bradley, J., Peacock, G., Krug, S., et al. (2014). Pediatric Anthrax Clinical Management. Pediatric Anthrax Clinical Management. Pediatrics. 133(5):E1411-E1436.
This clinical report provides guidance on the prophylaxis and treatment of patients up to age 21 following an intentional anthrax release, with particular focus on areas where clinical recommendations for children differ from those for adults. The report discusses clinical presentations, post-exposure prophylaxis, infection control, management of patients with suspected and confirmed anthrax, and special considerations for breastfeeding infants.
Favorite:
You must Login to add a comment
  • This item doesn't have any comments
Cooper, W., Hernandez-Diaz, S., Arbogast, P., et al. (2009). Antibiotics Potentially Used in Response to Bioterrorism and the Risk of Major Congenital Malformations. Pediatric and Perinatal Epidemiology. 23(1):18-28.
The authors compared infants with fetal exposure to several antibiotics recommended for use following a bioterror attack and one antibiotic not recommended for such use to infants with no fetal exposure to antibiotics to assess the risk of major congenital malformations from pregnancy-related exposures to antibiotics in the event of bioterrorism. Study findings suggest that fetal exposure to ciprofloxacin, azithromycin, doxycycline, or amoxicillin following a bioterror attack should not result in a greater incidence of major congenital malformations overall, but additional research is needed.
Favorite:
You must Login to add a comment
  • This item doesn't have any comments
Disaster Preparedness Advisory Council. (2016). Medical Countermeasures for Children in Public Health Emergencies, Disasters, or Terrorism. Pediatrics. 137(2).
The Council shares that many medical countermeasures (MCM) are more likely to be approved for adult use and may not take the unique needs of children into account. They drafted this policy statement to suggest recommendations that address the gaps for the development and use of MCMs in children during public health emergencies or disasters.
Favorite:
You must Login to add a comment
  • This item doesn't have any comments
Griese, S., Kisselburgh, H., Bartenfeld, M., et al. (2018). Pediatric Botulism and Use of Equine Botulinum Antitoxin in Children: A Systematic Review. Clinical Infectious Diseases. 66(suppl_1):s17-s29.
The authors conducted a systematic review of peer-reviewed and non-peer-reviewed literature to identify signs and symptoms that may aid diagnosis of botulism in children. They also described the effects of botulinum antitoxin in the pediatric population.
Favorite:
You must Login to add a comment
  • This item doesn't have any comments
Hamele, M., Poss, W., and Sweney, J. (2014). Disaster Preparedness, Pediatric Considerations in Primary Blast Injury, Chemical, and Biological Terrorism. World Journal of Critical Care Medicine. 3(1):15-23.
The authors review the presentation, pathophysiology, and treatment of pediatric victims of blast injury, chemical weapons, and biological weapons, with a focus on those injuries not commonly encountered in critical care practice.
Favorite:
You must Login to add a comment
  • This item doesn't have any comments
* National Biodefense Science Board. (2011). Challenges in the Use of Anthrax Vaccine Adsorbed (AVA) in the Pediatric Population as a Component of Post-Exposure Prophylaxis (PEP).
The Board explored challenges regarding Anthrax Vaccine Absorbed (AVA) and considered options for pre- and post-event research. AVA is not licensed for use in children and there is no clinical data on its use in pediatric populations for pre- or post-exposure prophylaxis in children. The Board recommended that HHS plan and conduct a pre-event research study.
Favorite:
You must Login to add a comment
  • This item doesn't have any comments
Siegal, D., Strauss-Riggs, K. et al. (2014). Prioritization of Pediatric CBRNE Disaster Education and Training Needs. Clinical Pediatric Emergency Medicine. 15(4):309-317.
This article summarizes the 2011 Pediatric Disaster Preparedness Conference convened by the National Center for Disaster Medicine and Public Health. Multidisciplinary subject matter experts identified and prioritized roles in need of training in three settings: EMS/first responder, hospitals, and ambulatory care. For each role in each setting, experts identified training topics, key content, and level of training required. The authors suggest that a steering committee oversee development and implementation of related curriculum.
Favorite:
You must Login to add a comment
  • This item doesn't have any comments
U.S. Food and Drug Administration. (2018). Pediatric Medical Countermeasures.
Pediatric patients may react differently to certain medications, making the development of safe and effective medical countermeasures (MCM) for young patients critical to public health emergency preparedness. This webpage includes links to resources specific to bioterrorism emergencies and radiation emergencies.
Favorite:
You must Login to add a comment
  • This item doesn't have any comments

Plans, Tools, and Templates

Administration for Strategic Preparedness and Response. (2021). National Health Security Strategy. U.S. Department of Health and Human Services.
The goal of the National Health Security Strategy (NHSS) is to strengthen and sustain communities’ abilities to prevent, protect against, mitigate the effects of, respond to, and recover from disasters and emergencies. This webpage includes links to the full text of the strategy, an overview, the NHSS Implementation Plan, the NHSS Evaluation of Progress, and an NHSS Archive.
Favorite:
3
You must Login to add a comment
  • This item doesn't have any comments
Agency of Healthcare Research & Quality (AHRQ). (2004). Community-Based Mass Prophylaxis: A Planning Guide for Public Health Preparedness. Agency for Healthcare Research and Quality.
Planning guide to help state, county, and local officials meet federal requirements to prepare for public health emergencies. Outlines five components of mass prophylaxis response to epidemic outbreaks. Addresses dispensing operations using a comprehensive operational structure for Dispensing/Vaccination Centers (DVCs) based on the National Incident Management System (NIMS).
Favorite:
You must Login to add a comment
  • This item doesn't have any comments
Alabama Department of Public Health. (n.d.). Hospital Template for Serious Infectious Disease Procedures. (Accessed 3/17/2021.)
This eight-page template is for the use of hospital administration and planning personnel to identify and communicate key elements of the policy and procedures for screening, identification, and initial management of a suspected serious infectious disease patient. It is intended to be used as a tool to assist in the effective preparation for, implementation, and execution of facility serious infectious disease response plans.
Favorite:
You must Login to add a comment
  • This item doesn't have any comments
American Biological Safety Association. (n.d.). Select Agents Fact Sheet. (Accessed 7/10/19.)
This fact sheet lists diseases, their pathogen, genus species, host range, transmission, symptoms, incubation period, and available treatments. Presents a wide range of pathogens and their general presentation and treatment in a very brief table format.
Favorite:
You must Login to add a comment
  • This item doesn't have any comments
APIC Bioterrorism Task Force and CDC Hospital Infections Program Bioterrorism Working Group. (1999). Bioterrorism Readiness Plan: A Template for Healthcare Facilities.
In cooperation with the Centers for Disease Control and Prevention (CDC), APIC produced this Bioterrorism Readiness Plan to serve as a reference document and initial template to facilitate preparation of bioterrorism readiness plans for individual institutions.
Favorite:
You must Login to add a comment
  • This item doesn't have any comments
ASPR TRACIE. (2021). Step-by-Step Guide to Implementing the Coalition Infectious Disease Annex TTX Template (PDF).
This guide is part of a toolkit that can help emergency planners create an interactive, discussion-based exercise focusing on impacts to healthcare coalition and healthcare facilities caused by large numbers of patients seeking healthcare following exposure to an infectious agent.
Favorite:
You must Login to add a comment
  • This item doesn't have any comments
Association of Public Health Laboratories. (2013). Infectious Disease Planning and Response Framework Checklist. (Log in required.)
This checklist guides the actions to be taken by public health laboratories when a disease outbreak occurs or threat emerges. Covered categories include: partner and stakeholder actions, communications, safety, regulatory requirements, sample/specimen transport, testing, reporting and data management, staffing, and surge considerations
Favorite:
You must Login to add a comment
  • This item doesn't have any comments
Association of Public Health Laboratories. (2015). A Biosafety Checklist: Developing a Culture of Biosafety.
This comprehensive checklist is intended to assist laboratories in assessing their biosafety practices and planning for emergencies. It is divided into 6 sections beginning with risk assessment and includes a list of planning resources for each section.
Favorite:
You must Login to add a comment
  • This item doesn't have any comments
Association of Public Health Laboratories. (2015). Surge Capacity Planning Tool for the Laboratory Response Network for Biological Threats Preparedness (LRN-B).
This tool is intended to assist laboratories in assessing their surge capacity. The authors recommend laboratories review the tool annually or any time their space allocation, instruments, or staffing change.
Favorite:
You must Login to add a comment
  • This item doesn't have any comments
Association of Public Health Laboratories. (2017). Biothreat Agent Bench Cards for the Sentinel Laboratory.
In cooperation with the Centers for Disease Control and Prevention (CDC), APIC produced this Bioterrorism Readiness Plan to serve as a reference document and initial template to facilitate preparation of bioterrorism readiness plans for individual institutions. Some recommendations and language are dated. Brucella species, Burkholderia mallei, Burkholderia pseudomallei, Francisella tularensis, and Yersinia pestis. The deck also includes information about the Laboratory Response Network and biochemical reactions, a checklist for sentinel clinical laboratories, and a select agent response algorithm.
Favorite:
You must Login to add a comment
  • This item doesn't have any comments
Association of Public Health Laboratories. (2022). Algorithm and Guidelines for Responding to an Incident Involving a Suspicious Non-Clinical Sample, Version 3.0.
This model practice provides guidelines to public health laboratories and first responders on their respective actions during an incident involving a suspicious sample.
Favorite:
You must Login to add a comment
  • This item doesn't have any comments
Association of Public Health Laboratories and American Society for Microbiology. (2016). Clinical Laboratory Preparedness and Response Guide.
This comprehensive guide includes tools and standards that can help laboratories recognize that a specimen contains a biological threat agent, handle said specimens, and notify appropriate state and federal partners. It includes helpful graphics, charts, and links to related resources.
Favorite:
You must Login to add a comment
  • This item doesn't have any comments
Federal Emergency Management Agency. (2023). Biological Incident Annex to the Response and Recovery Federal Interagency Operational Plans.
This document describes the framework for the federal government’s response to and recovery from a naturally-occurring or terrorist-caused biological incident. The annex consists of a base annex that applies to all biological incidents and a branch plan for suspected or actual biological attacks.
Favorite:
You must Login to add a comment
  • This item doesn't have any comments
Los Angeles County Department of Public Health and Los Angeles County Emergency Medical Services Agency. (2012). Terrorism Agent Information and Treatment Guidelines for Clinicians and Hospitals.
Clinicians and others can use this manual to further their knowledge on bioterrorism agents, chemical and radiological terrorism, infection control, and management of exposed persons.
Favorite:
You must Login to add a comment
  • This item doesn't have any comments
Minnesota Department of Health, Association for Professionals in Infection Control and Epidemiology - Minnesota, and Health Care Coalitions of Minnesota. (2019). High Consequence Infectious Disease (HCID) Toolbox for Frontline Health Care Facilities.
This toolbox includes a variety of resources to assist frontline facilities in their readiness activities related to patients with high consequence infectious diseases. Included are planning and training tools, exercise templates, and the components (e.g., screening guide, checklists, posters) to create a readiness binder.
Favorite:
You must Login to add a comment
  • This item doesn't have any comments
* Misener, M., Starr, D., Scaccia, A., and Arya, V. (2018). Screening for Anthrax Postexposure Antibiotic Prophylaxis—The New York City Approach. Health Security. 16(4).
The authors explain the city's anthrax antibiotic screening algorithm in the event of a deliberate anthrax release. They also share reasons behind the use and exclusion of screening questions and explain how they plan to incorporate additional medical evaluation as necessary.
Favorite:
You must Login to add a comment
  • This item doesn't have any comments
National Ebola Training and Education Center. (n.d.). NETEC Exercise Templates. (Accessed 9/9/2024.)
This web page includes links to various Homeland Security Exercise and Evaluation Program-compliant templates to assist healthcare coalitions, frontline facilities, assessment hospitals, state-designated Ebola treatment centers, regional Ebola and special pathogen treatment centers, and their respective response partners in the planning and conduct of exercises on the identification, assessment, treatment, management, transport, and transfer of high risk patients. The site includes templates for drills, tabletops, functional, and full-scale exercises. There is also a beginners guide to assist users new to exercise planning.
Favorite:
You must Login to add a comment
  • This item doesn't have any comments
National Emerging Special Pathogens Training and Education Center. (2023). Long-Term Care Special Pathogens Infection Prevention and Control Workbook. (Free with registration.)
This workbook assists long-term care facilities assess their readiness for special pathogens and improve their infection prevention programs.
Favorite:
You must Login to add a comment
  • This item doesn't have any comments
New York City Health + Hospitals. (2019). Frontline Hospital Planning Guide: Special Pathogens.
This planning guide from New York City Health + Hospitals provides high-level planning information for frontline hospital multidisciplinary teams to support planning and training for the initial care of suspected special pathogen patients while determining whether and when they will be transferred to another facility for further assessment and treatment.
Favorite:
You must Login to add a comment
  • This item doesn't have any comments
San Francisco Department of Public Health. (2011). Infectious Disease Emergency Response Plan.
This plan contains the following sections: command, plans section (by unit), operations section, logistics, and finance. Four annexes that focus on different threats are included, as are sample forms and other appendices.
Favorite:
You must Login to add a comment
  • This item doesn't have any comments
The Society for Healthcare Epidemiology of America. (2017). Outbreak Response Training Program (ORTP). (Free account required.)
This webpage contains links to four free toolkits that were developed to provide healthcare providers immediate access to key infectious disease outbreak information and resources. The toolkits contain guidance on incident management, emerging pathogens, IPC strategies, COVID-19, communication, negotiation, and implementation. Each toolkit contains checklists, guidance documents, case studies, and fillable tables to meet the planning and response needs prior to or during an infectious disease outbreak.
Favorite:
You must Login to add a comment
  • This item doesn't have any comments
* Toner, E., Shearer, M., Kirk Sell, T., et al. (2017). Health Sector Resilience Checklist for High Consequence Infectious Diseases – Informed by the Domestic U.S. Ebola Response. Johns Hopkins Bloomberg School of Public Health Center for Health Security.
This document provides action steps for responding to isolated cases or limited outbreaks of high-consequence infectious diseases, including those that are: novel or rare in the community, moderate to highly contagious, moderate to highly lethal, not easily controlled by medical countermeasures and other interventions, and have the potential to cause exceptional public concern. The document includes a general checklist and population-specific checklists for public health, healthcare, emergency medical services, and elected officials.
Favorite:
You must Login to add a comment
  • Bridget Kanawati Thank you for letting us know. The link has been updated with the new URL.
    7/27/2023 10:32:26 AM
  • Jonathan Pearson This link seems to be broken.
    7/27/2023 10:07:17 AM
U.S. Army Medical Research Institute on Infectious Diseases. (2012). Pocket Reference Guide to Biological Select Agents and Toxins.
This guide can help clinicians and other healthcare providers recognize bioagent diseases. It includes an overview table showing risk factors followed by one page overviews of the signs and symptoms, diagnostic tools, treatment, and precautions for various agents and toxins.
Favorite:
You must Login to add a comment
  • This item doesn't have any comments
* U.S. Department of Homeland Security. (2012). Urban Area Recovery Planning with CBR (Chemical, Biological, Radiological Hazards: Lessons Learned from Seattle and Denver).
This planning aid can help multijurisdictional urban area planners manage the recovery from a biological, chemical, or radiological event. Developed from lessons learned during events in Seattle (WA) and Denver (CO), the document provides a recovery planning template along with corresponding planning support annexes for each of the three hazards.
Favorite:
You must Login to add a comment
  • This item doesn't have any comments
United States Army Medical Research Institute of Infectious Diseases. (2021). USAMRIID's Biodefense Tool.
This app is built on the Medical Management of Chemical and Biological Casualties course taught by USAMRIID and can help first responders identify and treat conditions related to biological agents. (For Android devices, visit https://play.google.com/store/apps/details?id=com.tradocmobile.bio&hl=en&gl=US.)
Favorite:
You must Login to add a comment
  • This item doesn't have any comments

Specific Threats: Anthrax

Bower, W., Hendricks, K., Pillai, S., et al. (2015). Clinical Framework and Medical Countermeasure Use During an Anthrax Mass-Casualty Incident. Morbidity and Mortality Weekly Report. 64(RR04):1-28. .
This report can help clinicians, hospital administrators, state and local health officials, and planners develop crisis protocols for an anthrax mass casualty incident. The authors share a clinical framework for the adaptation of existing evidence-based guidance and rational use of stockpiled medical countermeasures for the treatment of anthrax during a mass-casualty incident that triggers a shift to contingency or crisis standards of care. This framework addresses elements of hospital-based acute care (e.g., prioritization of antitoxins, intravenous antimicrobial use, and the diagnosis and management of common anthrax-specific complications).
Favorite:
You must Login to add a comment
  • This item doesn't have any comments
Centers for Disease Control and Prevention. (2016). Emergency Use of Ciprofloxacin.
This webpage provides links to factsheets for healthcare providers and others on the use of ciprofloxacin in the event of a mass casualty incident involving anthrax.
Favorite:
You must Login to add a comment
  • This item doesn't have any comments
Centers for Disease Control and Prevention. (2017). Anthrax.
This webpage includes information on the types of anthrax, prevention, testing, treatment, and targeted resources for specific groups.
Favorite:
You must Login to add a comment
  • This item doesn't have any comments
Centers for Disease Control and Prevention. (2018). Anthrax (Bacillus anthracis) Case Definition.
This case definition provides a description of each clinical type of anthrax, clinical criteria for surveillance, laboratory criteria for diagnosis, epidemiological linkages, criteria to distinguish new cases, and suspected, probable, and confirmed case classifications
Favorite:
You must Login to add a comment
  • This item doesn't have any comments
Centers for Disease Control and Prevention. (2023). CDC Guidelines for the Prevention and Treatment of Anthrax, 2023. Morbidity and Mortality Weekly Report (MMWR). 72(6):1-47.
This report provides an update to CDC guidance for prevention and treatment of exposure to anthrax, based on systematic reviews of the literature. This report improves on past CDC recommendations by providing alternative antimicrobial drug recommendations when first line treatments are contraindicated. It also provides information on diagnosis and treatment of anthrax meningitis.
Favorite:
You must Login to add a comment
  • This item doesn't have any comments
Goel, A. (2018). Anthrax: A Disease of Biowarfare and Public Health Importance.
This article reviews the history, biology, life cycle, pathogenicity, virulence, epidemiology and potential of anthrax as a biological weapon. The author suggests that active surveillance, proper animal immunization, and awareness can result in the rapid and accurate diagnosis for treatment and implementation of control strategies to prevent further disease spread. The author concludes that rapid and inexpensive serodiagnosis tests can serve as strong tools for surveillance of anthrax and that active surveillance can minimize the risks of agriculture- or occupation-related anthrax.
Favorite:
You must Login to add a comment
  • This item doesn't have any comments
Hendricks, K., Wright, M., Shadomy, S., et al. (2018). Centers for Disease Control and Prevention Expert Panel Meetings on Prevention and Treatment of Anthrax in Adults. Emerging Infectious Diseases. 20(2):e130687.
This article provides an overview of the panel discussions of anthrax experts convened by the Centers for Disease Control and Prevention to review and update guidelines for prevention and treatment of anthrax. The authors discuss anthrax pathogenicity and provide guidelines on: critical care measures and procedures, antimicrobial selection considerations for prevention and treatment, anthrax prevention, and the use of antitoxins.
Favorite:
You must Login to add a comment
  • This item doesn't have any comments
Huang, E., Pillai, S., Bower, W., et al. (2014). Antitoxin Treatment of Inhalation Anthrax: A Systematic Review. Health Security. 13(6):365-377.
The authors completed a systematic review (albeit with limited data) of human and animal studies on antitoxin treatment of inhalational anthrax. They found that early treatment with antimicrobial monotherapy or antimicrobial-antitoxin therapy were both associated with survival in animal studies. When treatment was delayed in animal studies, data suggested improved survivability for antimicrobial-antitoxin therapy compared to antimicrobial monotherapy. During large-scale anthrax incidents in which demand for antitoxin may exceed supply, the authors suggest that antitoxins be reserved for those who present with severe illness at onset but have a reasonable chance of survival and those who have not shown a clinical benefit from antimicrobials alone. The authors discussed numerous limitations to their study and emphasized the need for additional research.
Favorite:
You must Login to add a comment
  • This item doesn't have any comments
Inglesby, T., Henderson, D., Bartlett, J. (2000). Anthrax as a Biological Weapon: Medical and Public Health Management. Working Group on Civilian Biodefense. (Abstract only.)
This article highlights recommendations developed by the Working Group on Civilian Biodefense regarding a terrorist event featuring the release of Anthrax. The group provides a list of symptoms and treatment suggestions. Some recommendations may be dated but the article provides an excellent overview of Anthrax as a weapon.
Favorite:
You must Login to add a comment
  • This item doesn't have any comments
Katharios-Lanwermeyer, S., Holty, J., Person, M., et al. (2016). Identifying Meningitis During an Anthrax Mass Casualty Incident: Systematic Review of Systemic Anthrax Since 1880. Clinical Infectious Disease. 62(12):1537-1545 .
Based on a systematic review of 132 cases of anthrax meningitis, the authors developed a four item, evidence-based screening tool to assess severe headache, altered mental status, meningeal signs, and other neurological signs. The authors suggest that patients who screen positive on two or more of the responses could be categorized as presumptive anthrax meningitis. Use of the tool could improve patient outcomes and resource allocation during an anthrax mass casualty incident.
Favorite:
You must Login to add a comment
  • This item doesn't have any comments
Kyriacou, D., Dobrez, D., Parada, J., et al. (2012). Cost-Effectiveness Comparison of Response Strategies to a Large-Scale Anthrax Attack on the Chicago Metropolitan Area: Impact of Timing and Surge Capacity. Biosecurity Bioterrorism 10(3): 264-279.
The authors examined the cost-effectiveness of a response to an anthrax attack based on pre- and post-attack prophylaxis and/or vaccination. Their results indicated that post-attack antibiotic prophylaxis and vaccination of all exposed people would be the most cost-effective response strategy for a large-scale anthrax attack.
Favorite:
You must Login to add a comment
  • This item doesn't have any comments
Meaney-Delman, D., Zotti, M., Creanga, A., et al. (2014). Special Considerations for Prophylaxis for and Treatment of Anthrax in Pregnant and Postpartum Women. Emerging Infectious Diseases. 20(2). .
The authors present information regarding vaccine, antimicrobial drug prophylaxis and treatment, clinical considerations, and other factors healthcare practitioners must take into consideration when treating pregnant and postpartum women after an anthrax exposure.
Favorite:
You must Login to add a comment
  • This item doesn't have any comments
Merkel, T., Perera, P., Kelly, V., et al. (2010). Development of a Highly Efficacious Vaccinia-Based Dual Vaccine Against Smallpox and Anthrax, Two Important Bioterror Entities.
The authors integrated the cytokine IL-15 and the PA gene of B. anthracis into the Wyeth strain of vaccina virus derived from the licensed smallpox vaccine to create a dual vaccine effective against both smallpox and anthrax. Studies in rabbits and mice demonstrated superior immunogenicity and efficacy of Wyeth/IL-15/PA compared to existing licensed smallpox and anthrax vaccines.
Favorite:
You must Login to add a comment
  • This item doesn't have any comments
* Misener, M., Starr, D., Scaccia, A., and Arya, V. (2018). Screening for Anthrax Postexposure Antibiotic Prophylaxis—The New York City Approach. Health Security. 16(4).
The authors explain the city's anthrax antibiotic screening algorithm in the event of a deliberate anthrax release. They also share reasons behind the use and exclusion of screening questions and explain how they plan to incorporate additional medical evaluation as necessary.
Favorite:
You must Login to add a comment
  • This item doesn't have any comments
* National Biodefense Science Board. (2011). Challenges in the Use of Anthrax Vaccine Adsorbed (AVA) in the Pediatric Population as a Component of Post-Exposure Prophylaxis (PEP).
The Board explored challenges regarding Anthrax Vaccine Absorbed (AVA) and considered options for pre- and post-event research. AVA is not licensed for use in children and there is no clinical data on its use in pediatric populations for pre- or post-exposure prophylaxis in children. The Board recommended that HHS plan and conduct a pre-event research study.
Favorite:
You must Login to add a comment
  • This item doesn't have any comments
Rainisch, G., Meltzer, M., Shadomy, S., et al. (2017). Modeling Tool for Decision Support During Early Days of an Anthrax Event. Emerging Infectious Diseases. 23(1): 46-55.
The authors developed a model based on the first three days of case data to project cases, peak hospital caseload, and deaths from an inhalational anthrax incident and the effects of interventions on these projections.
Favorite:
You must Login to add a comment
  • This item doesn't have any comments
Rubinson, L., Corey, A., & Hanfling, D. (2017). Estimation of Time Period for Effective Human Inhalational Anthrax Treatment Including Antitoxin Therapy. PLoS Currents. 9.
The authors provide guidance for effective post exposure treatment periods to assist healthcare practitioners with the management of large populations exposed to inhalation anthrax. Their results indicated administering antitoxins along with antibiotics could potentially provide an increased postexposure treatment period in comparison to solely antibiotic treatment.
Favorite:
You must Login to add a comment
  • This item doesn't have any comments
U.S. Department of Health and Human Services. (2015). Anthrax Medical Countermeasures-Amendment.
This amendment includes an updated “description of covered countermeasures and the disease threat; extend[s] the effective time period of the declaration;” and clarifies the terms of the declaration.
Favorite:
You must Login to add a comment
  • This item doesn't have any comments
U.S. Department of Health and Human Services, U.S. Department of Homeland Security, U.S. Department of Labor, and U.S. Environmental Protection Agency. (2012). Guidance for Protecting Responders’ Health During the First Week Following a Wide-Area Aerosol Anthrax Attack.
This document provides guidance on post-exposure prophylaxis and vaccination, personal protective equipment, personal decontamination and hygiene, administrative and engineering controls, and pre-event vaccination for first responders, emergency management staff, public health and medical professionals, skilled support personnel, and critical infrastructure personnel who participate in the response to an anthrax attack.
Favorite:
You must Login to add a comment
  • This item doesn't have any comments
U.S. Food and Drug Administration. (2023). Anthrax.
This webpage provides information on and links to resources specific to vaccines approved to prevent disease.
Favorite:
You must Login to add a comment
  • This item doesn't have any comments
Wright, J., Quinn, C., Shadomy, S., et al. (2010). Use of Anthrax Vaccine in the United States: Recommendations of the Advisory Committee on Immunization Practices (ACIP), 2009. Morbidity and Mortality Weekly Report. 59(RR06):1-30 .
This Mortality and Morbidity Weekly Report provides recommendations from the Advisory Committee on Immunization Practices (ACIP) for anthrax vaccine adsorbed (AVA). The report discusses updated information on anthrax epidemiology, and summarizes the evidence regarding the effectiveness and efficacy, immunogenicity, and safety of the AVA vaccine. Authors identify areas for future research and conclude by providing recommendations for pre-exposure and post-exposure use in general and specific subpopulations, including children, pregnant and breastfeeding women, and those with various occupational exposures.
Favorite:
You must Login to add a comment
  • This item doesn't have any comments

Specific Threats: Botulism

Arnon, S., Schechter, R., Inglesby, T., et al. (2001). Botulinum Toxin as a Biological Weapon. Journal of the American Medical Association, 285(16):2081.
This article highlights recommendations developed by the Working Group on Civilian Biodefense regarding a terrorist event featuring the release of botulinum toxin. The group provides a list of symptoms and treatment suggestions. Some recommendations may be dated but the article provides an excellent overview of Botulism as a weapon.
Favorite:
You must Login to add a comment
  • This item doesn't have any comments
Centers for Disease Control and Prevention. (n.d.). Botulism. (Accessed 7/10/2019.)
This webpage includes basic information about botulism, prevention, symptoms, diagnosis, treatment, and resources for specific populations.
Favorite:
You must Login to add a comment
  • This item doesn't have any comments
Centers for Disease Control and Prevention. (2018). Botulism (Clostridium botulinum) 2011 Case Definition.
This case definition provides clinical descriptions, laboratory criteria for diagnosis, and case classification for foodborne, infant, wound, and other subtypes of botulism.
Favorite:
You must Login to add a comment
  • This item doesn't have any comments
McCarty, C., Angelo, K., Beer, K., et al. (2015). Notes from the Field: Large Outbreak of Botulism Associated with a Church Potluck Meal - Ohio, 2015. Morbidity and Mortality Weekly Report (MMWR).64(29):802-803.
This report provides a summary of the 2015 botulism outbreak in Fairfield County, Ohio. The authors review the public health and medical response from the initial onset of the outbreak through the investigation and identification of the botulism source. The report highlights the importance of coordination among healthcare responders during botulism outbreaks.
Favorite:
You must Login to add a comment
  • This item doesn't have any comments
Rao, A., Lin, N., Griese, S., et al. (2018). Clinical Criteria to Trigger Suspicion for Botulism: An Evidence-Based Tool to Facilitate Timely Recognition of Suspected Cases During Sporadic Events and Outbreaks.
The authors created a tool to aid in clinical assessment for botulism based on frequency of signs and symptoms of confirmed cases. While the tool cannot be used for diagnostic purposes, the authors suggest it can be useful in triaging patients and helping clinicians identify possible cases.
Favorite:
You must Login to add a comment
  • This item doesn't have any comments
Rao, A., Lin, N., Griese, S., et al. (2018). Pediatric Botulism and Use of Equine Botulinum Antitoxin in Children: A Systematic Review. Clinical Infectious Diseases. 66(suppl_1):s17-s29.
The authors conducted a systematic review of peer-reviewed and non-peer-reviewed literature to identify signs and symptoms that may aid diagnosis of botulism in children. They also described the effects of botulinum antitoxin in the pediatric population.
Favorite:
You must Login to add a comment
  • This item doesn't have any comments
Rao, A., Sobel, J., Chatham-Stephens, K., and Luquez, C. (2021). Clinical Guidelines for Diagnosis and Treatment of Botulism, 2021. Morbidity and Mortality Weekly Report. 70(2):1-30.
These clinical guidelines provide background information on botulism and details about diagnosis and treatment. Considerations are included for conventional, contingency, and crisis care.
Favorite:
You must Login to add a comment
  • This item doesn't have any comments

Specific Threats: Dual Use Research

DiEuliis, D., and Gronvall, G. (2018). A Holistic Assessment of the Risks and Benefits of the Synthesis of Horsepox. mSphere. 3(2):e00074-18.
This study reviews the re-creation of the horsepox virus and provides an analytical framework to assess the risks and potential benefits of dual use research. The researchers also provide insight on the biodefense enterprise in the U.S., which includes the acquisition of medical countermeasures. The authors conclude risk/benefit assessments are needed at the onset of dual-use research, throughout the development process, and to inform communications about the research.
Favorite:
You must Login to add a comment
  • This item doesn't have any comments
National Academies of Sciences, Engineering, and Medicine. (2017). Dual Use Research of Concern in the Life Sciences: Current Issues and Controversies. The National Academies Press.
This report is based on a review of potential mechanisms to balance the open dissemination of research findings with concerns for biosecurity. The report recommends training on dual use research of concern, engagement of advisory bodies for monitoring and enforcement, international harmonization, engagement with international entities, guidelines for publishers, policy development and regulatory oversight, and increased public engagement.
Favorite:
You must Login to add a comment
  • This item doesn't have any comments
* National Academies of Sciences, Engineering, and Medicine. (2018). Biodefense in the Age of Synthetic Biology. The National Academies Press.
This report reviews the uses of synthetic biology and explores potential misuses. The authors develop a framework to assess the security concerns related to advances in synthetic biology, ranks those concerns, and identifies options that could help mitigate the concerns.
Favorite:
You must Login to add a comment
  • This item doesn't have any comments
National Research Council. (2009). A Survey of Attitudes and Actions on Dual Use Research in the Life Sciences: A Collaborative Effort of the National Research Council and the American Association for the Advancement of Science. The National Academies Press.
This report highlights results of a survey of AAAS life sciences members on their knowledge of and attitudes about dual use research. Among the findings, survey results indicated that many respondents had already taken precautionary measures in the absence of guidelines or restrictions on dual use research, were open to scientific community-driven mechanisms to reduce risk, supported training and education on dual use concerns, and agreed that the need exists to better define the scope of research of concern.
Favorite:
You must Login to add a comment
  • This item doesn't have any comments

Specific Threats: Other (VHF, Category B & C Agents)

American College of Emergency Physicians. (2022). ACEP Monkeypox Field Guide.
This field guide is a one-stop resource for emergency physicians for information about mpox. The field guide includes information about the pathogen and how it is transmitted, case definitions, clinical characteristics, infection prevention actions, specimen collection and handling instructions, treatment and patient management, exposure monitoring, vaccine guidance for occupational risk, and other special considerations.
Favorite:
You must Login to add a comment
  • This item doesn't have any comments
Anderson, A., Bijlmer, H., Fournier, P., et al. (2013). Diagnosis and Management of Q Fever – United States, 2013: Recommendations from CDC and the Q Fever Working Group. Morbidity and Mortality Weekly Report. 62(3):1-30.
This document describes the epidemiology, signs and symptoms, diagnosis, treatment and management, and surveillance and reporting of Q fever. Considerations for pregnant women, children, and occupational exposures are included.
Favorite:
You must Login to add a comment
  • This item doesn't have any comments
Centers for Disease Control and Prevention. (2010). Brucellosis (Brucella spp.) 2010 Case Definition.
This case definition provides a clinical description, laboratory criteria for diagnosis, and case classification for brucellosis.
Favorite:
You must Login to add a comment
  • This item doesn't have any comments
Centers for Disease Control and Prevention. (2012). About Melioidosis.
This webpage includes basic information on melioidosis (Whitmore’s disease; caused by Burkholderia pseudomallei) transmission, signs and symptoms, treatment, prevention, exposure risks, bioterrorism risks, and resources for specific groups
Favorite:
You must Login to add a comment
  • This item doesn't have any comments
Centers for Disease Control and Prevention. (2017). Q Fever.
This webpage includes basic information on Q fever (caused by Coxiella burnetii) transmission, signs and symptoms, treatment, prevention, diagnosis and testing, bioterrorism risks, and resources for specific groups.
Favorite:
You must Login to add a comment
  • This item doesn't have any comments
Centers for Disease Control and Prevention. (2024). Mpox in the United States and Around the World: Current Situation. U.S. Department of Health and Human Services.
This page includes various resources about monkeypox, including signs and symptoms, prevention, transmission, treatment, and information specific to clinicians, laboratory personnel, and veterinarians.
Favorite:
You must Login to add a comment
  • This item doesn't have any comments
Lipsitz, R., Garges, S., Aurigemma, R., et al. (2010). Workshop on Treatment of and Postexposure Prophylaxis for Burkholderia pseudomallei and B. mallei Infection, 2010. Emerging Infectious Diseases. 18(12) .
Workshop attendees reviewed the current state of knowledge on melioidosis and glanders (caused by Burkholderia pseudomallei and B. mallei infections) and developed consensus recommendations for postexposure prophylaxis and treatment. The authors emphasized the need for standardized animal models and B. pseudomallei strains for further research on therapeutic options and training of laboratorians and physicians to improve diagnosis and treatment.
Favorite:
You must Login to add a comment
  • This item doesn't have any comments
Nicol, E., Mepham, S., Naylor, J., et al. (2019). Aeromedical Transfer of Patients with Viral Hemorrhagic Fever. Emerging Infectious Diseases. 25(1):5-14.
The authors describe the aeromedical evacuation capabilities developed and maintained by the British Royal Air Force for patients with suspected or confirmed highly infectious diseases over the last 40 years. The authors describe their procedures and how they have been improved based on lessons learned from transporting patients.
Favorite:
You must Login to add a comment
  • This item doesn't have any comments
Reynolds, M., McCollum, A., Nguete, B., et al. (2017). Improving the Care and Treatment of Monkeypox Patients in Low-Resource Settings: Applying Evidence from Contemporary Biomedical and Smallpox Biodefense Research. Viruses. 9(12):380.
The authors provide an overview of monkeypox and note the lack of clinical management guidelines for monkeypox patients. They summarize clinical syndromes and possible treatment options, for both developed and low-resource settings, and offer performance indicators and clinical metrics for case management.
Favorite:
You must Login to add a comment
  • This item doesn't have any comments

Specific Threats: Plague

Centers for Disease Control and Prevention. (n.d.). Plague. (Accessed 7/10/2019.)
This webpage includes general information on plague, transmission, prevention, diagnosis, treatment, and resources for specific groups
Favorite:
You must Login to add a comment
  • This item doesn't have any comments
Centers for Disease Control and Prevention. (2010). Plague (Yersinia pestis) 1996 Case Definition.
This case definition provides a clinical description, laboratory criteria for diagnosis, and case classification for plague. The 1996 case definition was reviewed and republished by the Council of State and Territorial Epidemiologists in 2009. The 1996 and 2010 versions of the case definition are identical.
Favorite:
You must Login to add a comment
  • This item doesn't have any comments
Inglesby, T., Dennis, D., Henderson, D. et al. (2000). Plague as a Biological Weapon: Medical and Public Health Management. Journal of American Medical Association. 283(17): .
This article highlights recommendations developed by the Working Group on Civilian Biodefense regarding a terrorist event featuring the release of Plague. The group provides a list of symptoms and treatment suggestions. Some recommendations may be dated but the article provides an excellent overview of Plague as a weapon.
Favorite:
You must Login to add a comment
  • This item doesn't have any comments
Kool, J. (2005). Risk of Person-to-Person Transmission of Pneumonic Plague. Clinical Infectious Diseases. 40(8): 1166-1172.
The author reviews the historical literature and anecdotal evidence on plague transmission and discusses how simple protective measures can reduce the risk of infection.
Favorite:
You must Login to add a comment
  • This item doesn't have any comments
Nelson, C., Meaney-Delman, D., Fleck-Derderian, S., et al. (2021). Antimicrobial Treatment and Prophylaxis of Plague: Recommendations for Naturally Acquired Infections and Bioterrorism Response. Morbidity and Mortality Weekly Report. 70(3):1-27.
These guidelines provide recommendations to healthcare providers on treatment and prophylaxis of plague resulting from naturally occurring disease or a bioterrorism attack.
Favorite:
You must Login to add a comment
  • This item doesn't have any comments

Specific Threats: Smallpox

Centers for Disease Control and Prevention. (2017). Smallpox.
This webpage includes information on the history of smallpox, transmission, signs and symptoms, prevention and treatment, and resources for specific groups.
Favorite:
You must Login to add a comment
  • This item doesn't have any comments
Centers for Disease Control and Prevention. (2017). Smallpox Enhanced Surveillance and Case Reporting.
This webpage includes the case definition and case reporting requirements for smallpox.
Favorite:
You must Login to add a comment
  • This item doesn't have any comments
Centers for Disease Control and Prevention. (2018). Administering ACAM2000 Smallpox Vaccine Videos.
This series of videos introduces smallpox vaccination with ACAM2000; how to reconstitute, properly handle, and store the vaccine; administer using the multiple-puncture technique with a bifurcated needle; care for the vaccination site; identify common reactions; learn about potential serious adverse events and how to treat them; screen for contraindications and special populations; and learn about two products.
Favorite:
You must Login to add a comment
  • This item doesn't have any comments
Centers for Disease Control and Prevention. (2022). Smallpox Vaccines.
This webpage includes links to current smallpox vaccine recommendations developed by the Advisory Committee on Immunization Practices. Current guidance is available for: use of smallpox vaccine in laboratory and health care personnel at risk for occupational exposure to orthopoxviruses, notice of newly licensed vaccine, surveillance guidelines for vaccine adverse reactions, and recommendations for using smallpox vaccine in a pre-event vaccination program.
Favorite:
You must Login to add a comment
  • This item doesn't have any comments
Food and Drug Administration. (2019). Smallpox Preparedness and Response Updates from FDA.
This webpage includes information on smallpox facts, medical countermeasures, consumer protection, and smallpox updates and additional industry guidance.
Favorite:
You must Login to add a comment
  • This item doesn't have any comments
Henderson, D., Inglesby, T., Bartlett, J. (1999). Smallpox as a Biological Weapon: Medical and Public Health Management. Journal of American Medical Association. 281(22): 2127-2137.
This article highlights recommendations developed by the Working Group on Civilian Biodefense regarding a terrorist event featuring the release of Smallpox. The group provides a list of symptoms and treatment suggestions. Some recommendations may be dated but the article provides an excellent overview of Smallpox as a weapon.
Favorite:
You must Login to add a comment
  • This item doesn't have any comments
Macintyre, C., Costantino, V., Chen, X., et al. (2018). Influence of Population Immunosuppression and Past Vaccination on Smallpox Reemergence. Emerging Infectious Diseases. 24(4):646-53 .
The authors developed a SEIR (susceptible, exposed, infected, recovered) smallpox transmission model for New York City and Sydney, Australia that accounted for age-specific population immunosuppression and residual vaccine immunity. They found that residual immunity was less influential on disease rates in Sydney, which has a vaccination coverage rate half that of New York, and that age-specific death rates were lower in older age groups with higher residual immunity in both cities. Infection and death rates increased in both cities when immunosuppressed parameters were included in the model.
Favorite:
You must Login to add a comment
  • This item doesn't have any comments
Merkel, T., Perera, P., Kelly, V., et al. (2010). Development of a Highly Efficacious Vaccinia-Based Dual Vaccine Against Smallpox and Anthrax, Two Important Bioterror Entities. Proceedings of the National Academy of Sciences. 107(42):18092-18096.
The authors integrated the cytokine IL-15 and the PA gene of B. anthracis into the Wyeth strain of vaccina virus derived from the licensed smallpox vaccine to create a dual vaccine effective against both smallpox and anthrax. Studies in rabbits and mice demonstrated superior immunogenicity and efficacy of Wyeth/IL-15/PA compared to existing licensed smallpox and anthrax vaccines.
Favorite:
You must Login to add a comment
  • This item doesn't have any comments
Milton, D. (2012). What was the Primary Mode of Smallpox Transmission? Implications for Biodefense. Frontiers in Cellular and Infection Microbiology. 2:150.
Based on a review of existing data and knowledge on smallpox, the author examines whether traditional modeling based primarily on transmission to close contacts via large droplets fully accounts for the possibility of transmission via airborne droplet nuclei through mechanically-recirculated air in the modern built environment.
Favorite:
You must Login to add a comment
  • This item doesn't have any comments
* National Academies of Sciences, Engineering, and Medicine. (2005). The Smallpox Vaccination Program: Public Health in the Age of Terrorism.
This document reviews the Centers for Disease Control and Prevention’s implementation of its smallpox vaccination program. The report explores the history of smallpox and its control, provides a policy context for the program, offers a chronology of the program’s implementation, and discusses lessons learned.
Favorite:
You must Login to add a comment
  • This item doesn't have any comments
Petersen, B., Damon, I., Pertowski, C., et al. (2015). Clinical Guidance for Smallpox Vaccine Use in a Postevent Vaccination Program. Morbidity and Mortality Weekly Report. 64(RR02):1-26.
This report provides recommendations for the clinical use of the three smallpox vaccines included in the Strategic National Stockpile for persons exposed to the virus or at high risk for infection during a post-event vaccination program. Descriptions, administration and dosage, regulatory status, efficacy, and safety information are included for each vaccine. The report also includes recommendations on use, including considerations for contraindications and special populations, and identifies remaining knowledge gaps and areas for future research.
Favorite:
You must Login to add a comment
  • This item doesn't have any comments

Specific Threats: Tularemia

Centers for Disease Control and Prevention. (2017). Tularemia (Francisella tularensis) 2017 Case Definition.
This case definition provides clinical criteria, laboratory criteria for diagnosis, epidemiologic linkages, criteria to distinguish new cases, and class classification for tularemia.
Favorite:
You must Login to add a comment
  • This item doesn't have any comments
Centers for Disease Control and Prevention. (2018). Tularemia.
This webpage includes basic information on tularemia transmission, signs and symptoms, diagnosis and treatment, prevention, and resources for specific groups.
Favorite:
You must Login to add a comment
  • This item doesn't have any comments
Dennis, D., Inglesby, T., Henderson, D. (2001). Tularemia as a Biological Weapon: Medical and Public Health Management. Journal of the American Medical Association. 285(21): 2763-2773.
This article highlights recommendations developed by the Working Group on Civilian Biodefense regarding a terrorist event featuring the release of tularemia . The group provides a list of symptoms and treatment suggestions. While some recommendations may be dated, the authors share a helpful overview of the use of tularemia as a weapon
Favorite:
You must Login to add a comment
  • This item doesn't have any comments

Agencies and Organizations

Bipartisan Commission on Biodefense.
Favorite:
You must Login to add a comment
  • This item doesn't have any comments
Center for Health Security.
Favorite:
1
You must Login to add a comment
  • This item doesn't have any comments
Center for Infectious Disease Research and Policy. Biosecurity Issues.
Favorite:
You must Login to add a comment
  • This item doesn't have any comments
Center for Infectious Disease Research and Policy. Bioterrorism Issues.
Favorite:
You must Login to add a comment
  • This item doesn't have any comments
Centers for Disease Control and Prevention. Bioterrorism Agents/Diseases.
Favorite:
You must Login to add a comment
  • This item doesn't have any comments
National Association of County & City Health Officials. Infectious Disease.
Favorite:
You must Login to add a comment
  • This item doesn't have any comments
National Emerging Special Pathogens Training and Education Center.
Favorite:
You must Login to add a comment
  • This item doesn't have any comments
U.S. Department of Health and Human Services, National Institute of Allergy and Infectious Diseases. NIAID Emerging Infectious Diseases/Pathogens.
Favorite:
You must Login to add a comment
  • This item doesn't have any comments
U.S. Department of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response. 2017-2018 PHEMCE Strategy and Implementation Plan.
Favorite:
You must Login to add a comment
  • This item doesn't have any comments
U.S. Department of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response. Biomedical Advanced Research and Development Authority (BARDA).
Favorite:
You must Login to add a comment
  • This item doesn't have any comments
U.S. Department of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response. Project BioShield.
Favorite:
You must Login to add a comment
  • This item doesn't have any comments
U.S. Department of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response. Science Safety Security.
Favorite:
You must Login to add a comment
  • This item doesn't have any comments
U.S. Department of Health and Human Services, Office of the Assistant Secretary for Preparedness and Response. BARDA. Chemical, Biological, Radiological, and Nuclear (CBRN) Threat Programs.
Favorite:
You must Login to add a comment
  • This item doesn't have any comments
U.S. Department of Labor, Occupational Safety and Health Administration. Biological Agents.
Favorite:
You must Login to add a comment
  • This item doesn't have any comments
U.S. Environmental Protection Agency. Biological Quick Reference Cards.
Favorite:
You must Login to add a comment
  • This item doesn't have any comments
This ASPR TRACIE Topic Collection was comprehensively reviewed in July 2018 by the following subject matter experts (listed in alphabetical order): Eric R. Alberts, CEM, CHS-V, FPEM, FPEM-HC, CDP-1, CHPP, CHEP, SEM, CFRP, FABCHS, Manager, Emergency Preparedness, Orlando Health, Inc. (Hospital System); Gerrit Bakker, Senior Director, Public Health Preparedness, Association of State and Territorial Health Officials; James Bolen, MS, Planning and Operations Manager, Butler County (Ohio) Emergency Management Agency; Julie Bulson, MPA, BSN, RN, NE-BC, Director, Emergency Preparedness, Spectrum Health; Dan Hanfling, MD (Panel Chair, Editor) Contributing Scholar, UPMC Center for Health Security, Member, InterAgency Board, Attending Physician, BestPractices, Inc. (a division of EmCare), and Clinical Professor of Emergency Medicine, George Washington University; John Hick, MD, U.S. Department of Health and Human Services, Assistant Secretary for Preparedness and Response and Hennepin County Medical Center; Jodi Keller, RN, Associate Director of Healthcare System Emergency Preparedness, Central Ohio Trauma System; Jenna Mandel-Ricci, Vice President, Regulatory and Professional, Legal, Regulatory, and Professional Affairs, Greater New York Hospital Association; John O’Connor, MS, Associate Director for Communication Science, National Center for Emerging and Zoonotic Infectious Disease, Centers for Disease Control and Prevention; Terri Postma, MD Medical Officer Performance-Based Payment Policy Staff Centers for Medicare & Medicaid Services; Aaron Resnick, MA, Northwest Healthcare Response Network (Tukwila, WA); Mary Russell, EdD, MSN, Healthcare Emergency Response Coalition, Palm Beach County FL; and Brian Wilson, State Medical System Response Coordinator, Oklahoma Department of Health.
footer

Enter your email address to receive important announcements and updates through the ASPR TRACIE Listserv.